High purity factor VIII concentrates and HIV infection

C A Lee

Comment

C A Lee. BMJ. 1992.

. 1992 Mar 7;304(6827):641.

doi: 10.1136/bmj.304.6827.641.

C A Lee

No abstract available

Comment on

High potency factor VIII concentrates.
Mayne EE. Mayne EE. BMJ. 1992 Feb 1;304(6822):319. doi: 10.1136/bmj.304.6822.319-b. BMJ. 1992. PMID: 1739845 Free PMC article. No abstract available.

Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group.
Hilgartner MW, Buckley JD, Operskalski EA, Pike MC, Mosley JW. Hilgartner MW, et al. Lancet. 1993 May 29;341(8857):1373-4. doi: 10.1016/0140-6736(93)90943-b. Lancet. 1993. PMID: 8098792
Factor VIII concentrates in HIV-1-positive hemophiliacs--is pure better?
Eichinger S, Pabinger I, Kyrle PA, Köller U, Kier P, Schneider B, Lechner K. Eichinger S, et al. Haemostasis. 1992;22(1):25-31. doi: 10.1159/000216288. Haemostasis. 1992. PMID: 1521824
Hemofil-M study.
Rocino A, de Biasi R. Rocino A, et al. Ann Hematol. 1994;68 Suppl 3:S55-7. doi: 10.1007/BF01774535. Ann Hematol. 1994. PMID: 7910042 Clinical Trial. No abstract available.
Changes in CD4 count relative to product usage: findings from the transfusion safety study.
Hilgartner MW. Hilgartner MW. Semin Hematol. 1993 Oct;30(4 Suppl 5):7-9. Semin Hematol. 1993. PMID: 7903481 Review. No abstract available.
Long-term surveillance studies of previously untreated and treated patients, virally uninfected and infected patients--impact on the immune and other systems.
Poon MC. Poon MC. Ann Hematol. 1994;68 Suppl 3:S83-6. doi: 10.1007/BF01774544. Ann Hematol. 1994. PMID: 7910044 Review. No abstract available.